$ICN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VALEANT PHARMACEUTICALS INTERNATIONAL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in VALEANT PHARMACEUTICALS INTERNATIONAL. Get notifications about new insider transactions in VALEANT PHARMACEUTICALS INTERNATIONAL for free.
Page: < prev 1 2 3 4 5 5 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 15 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 23.59 | 50,000 | 1,179,500 | 17,486,503 | 17.4 M to 17.5 M (+0.29 %) |
Jul 15 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 23.34 | 50,000 | 1,167,000 | 17,436,503 | 17.4 M to 17.4 M (+0.29 %) |
Jul 15 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 22.94 | 50,000 | 1,147,000 | 17,386,503 | 17.3 M to 17.4 M (+0.29 %) |
Jul 07 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 24.16 | 50,000 | 1,208,000 | 17,086,503 | 17 M to 17.1 M (+0.29 %) |
Jul 07 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 24.95 | 5,110 | 127,495 | 17,036,503 | 17 M to 17 M (+0.03 %) |
Jul 07 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 24.99 | 2,400 | 59,976 | 17,031,393 | 17 M to 17 M (+0.01 %) |
Jul 10 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 22.78 | 100,000 | 2,278,000 | 17,336,503 | 17.2 M to 17.3 M (+0.58 %) |
Jul 10 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 22.92 | 100,000 | 2,292,000 | 17,236,503 | 17.1 M to 17.2 M (+0.58 %) |
Jul 10 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 23.69 | 50,000 | 1,184,500 | 17,136,503 | 17.1 M to 17.1 M (+0.29 %) |
Jul 01 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 24.99 | 900 | 22,491 | 17,028,993 | 17 M to 17 M (+0.01 %) |
Jul 01 2009 | ICN | VALEANT PHARMACEUT ... | STEFANO STEPHEN F. | Director | Grant | A | 0.00 | 339 | 0 | 9,290 | 9 K to 9.3 K (+3.79 %) |
Jul 01 2009 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Grant | A | 0.00 | 799 | 0 | 37,145 | 36.3 K to 37.1 K (+2.20 %) |
Jul 01 2009 | ICN | VALEANT PHARMACEUT ... | MELAS KYRIAZI THEO | Director | Grant | A | 0.00 | 363 | 0 | 43,229 | 42.9 K to 43.2 K (+0.85 %) |
Jul 01 2009 | ICN | VALEANT PHARMACEUT ... | LONNER ANDERS | Director | Grant | A | 0.00 | 629 | 0 | 8,279 | 7.7 K to 8.3 K (+8.22 %) |
Jul 01 2009 | ICN | VALEANT PHARMACEUT ... | KUGELMAN LARRY | Director | Grant | A | 0.00 | 351 | 0 | 33,249 | 32.9 K to 33.2 K (+1.07 %) |
Jul 01 2009 | ICN | VALEANT PHARMACEUT ... | KOPPES RICHARD | Director | Grant | A | 0.00 | 302 | 0 | 26,996 | 26.7 K to 27 K (+1.13 %) |
Jul 01 2009 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 629 | 0 | 37,367 | 36.7 K to 37.4 K (+1.71 %) |
Jun 26 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 24.93 | 25,000 | 623,250 | 17,028,093 | 17 M to 17 M (+0.15 %) |
Jun 26 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 24.59 | 1,600 | 39,344 | 17,003,093 | 17 M to 17 M (+0.01 %) |
Jun 26 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 24.47 | 25,000 | 611,750 | 17,001,493 | 17 M to 17 M (+0.15 %) |
Jun 23 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 23.74 | 50,000 | 1,187,000 | 16,976,493 | 16.9 M to 17 M (+0.30 %) |
Jun 23 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 23.92 | 39,100 | 935,272 | 16,926,493 | 16.9 M to 16.9 M (+0.23 %) |
Jun 23 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 23.79 | 50,000 | 1,189,500 | 16,887,393 | 16.8 M to 16.9 M (+0.30 %) |
Jun 18 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 23.29 | 50,000 | 1,164,500 | 16,837,393 | 16.8 M to 16.8 M (+0.30 %) |
Jun 18 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 23.01 | 77,724 | 1,788,429 | 16,787,393 | 16.7 M to 16.8 M (+0.47 %) |
Jun 18 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 22.83 | 100,000 | 2,283,000 | 16,709,669 | 16.6 M to 16.7 M (+0.60 %) |
Jun 16 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 22.98 | 100,000 | 2,298,000 | 16,609,669 | 16.5 M to 16.6 M (+0.61 %) |
Jun 11 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 23.00 | 68,085 | 1,565,955 | 16,509,669 | 16.4 M to 16.5 M (+0.41 %) |
Jun 11 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 22.53 | 100,000 | 2,253,000 | 16,441,584 | 16.3 M to 16.4 M (+0.61 %) |
Jun 11 2009 | ICN | VALEANT PHARMACEUT ... | CHAUDHURI BHASKAR | President | Grant | A | 0.00 | 6,010 | 0 | 96,729 | 90.7 K to 96.7 K (+6.62 %) |
Jun 09 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 22.91 | 100,000 | 2,291,000 | 16,341,584 | 16.2 M to 16.3 M (+0.62 %) |
Jun 09 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 23.20 | 100,000 | 2,320,000 | 16,241,584 | 16.1 M to 16.2 M (+0.62 %) |
Jun 09 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 23.25 | 8,391 | 195,091 | 16,141,584 | 16.1 M to 16.1 M (+0.05 %) |
Jun 04 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 23.30 | 100,000 | 2,330,000 | 16,133,193 | 16 M to 16.1 M (+0.62 %) |
Jun 04 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 23.08 | 100,000 | 2,308,000 | 16,033,193 | 15.9 M to 16 M (+0.63 %) |
Jun 04 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 23.61 | 50,000 | 1,180,500 | 15,933,193 | 15.9 M to 15.9 M (+0.31 %) |
Jun 04 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 23.51 | 50,000 | 1,175,500 | 15,883,193 | 15.8 M to 15.9 M (+0.32 %) |
May 29 2009 | ICN | VALEANT PHARMACEUT ... | STEFANO STEPHEN F. | Director | Grant | A | 0.00 | 38 | 0 | 8,951 | 8.9 K to 9 K (+0.43 %) |
May 29 2009 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Grant | A | 0.00 | 115 | 0 | 36,346 | 36.2 K to 36.3 K (+0.32 %) |
May 29 2009 | ICN | VALEANT PHARMACEUT ... | MELAS KYRIAZI THEO | Director | Grant | A | 0.00 | 57 | 0 | 42,866 | 42.8 K to 42.9 K (+0.13 %) |
May 29 2009 | ICN | VALEANT PHARMACEUT ... | KUGELMAN LARRY | Director | Grant | A | 0.00 | 57 | 0 | 32,898 | 32.8 K to 32.9 K (+0.17 %) |
May 26 2009 | ICN | VALEANT PHARMACEUT ... | CHAUDHURI BHASKAR | President | Buy | P | 22.19 | 1,352 | 30,001 | 90,719 | 89.4 K to 90.7 K (+1.51 %) |
May 19 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 19.89 | 33,200 | 660,348 | 15,833,193 | 15.8 M to 15.8 M (+0.21 %) |
May 19 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 19.75 | 19,989 | 394,783 | 15,799,993 | 15.8 M to 15.8 M (+0.13 %) |
May 19 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 19.82 | 3,075 | 60,947 | 15,780,004 | 15.8 M to 15.8 M (+0.02 %) |
May 18 2009 | ICN | VALEANT PHARMACEUT ... | CHAUDHURI BHASKAR | President | Buy | P | 22.06 | 1,360 | 30,002 | 89,367 | 88 K to 89.4 K (+1.55 %) |
May 14 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 19.54 | 100,000 | 1,954,000 | 15,776,929 | 15.7 M to 15.8 M (+0.64 %) |
May 14 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 19.56 | 100,000 | 1,956,000 | 15,676,929 | 15.6 M to 15.7 M (+0.64 %) |
May 14 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 19.78 | 100,000 | 1,978,000 | 15,576,929 | 15.5 M to 15.6 M (+0.65 %) |
May 14 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 19.67 | 75,000 | 1,475,250 | 15,476,929 | 15.4 M to 15.5 M (+0.49 %) |
May 14 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 19.76 | 125,000 | 2,470,000 | 15,401,929 | 15.3 M to 15.4 M (+0.82 %) |
May 14 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 19.86 | 80,000 | 1,588,800 | 15,276,929 | 15.2 M to 15.3 M (+0.53 %) |
May 14 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 19.85 | 68,115 | 1,352,083 | 15,196,929 | 15.1 M to 15.2 M (+0.45 %) |
May 14 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 19.85 | 100,000 | 1,985,000 | 15,128,814 | 15 M to 15.1 M (+0.67 %) |
May 14 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 19.83 | 90,000 | 1,784,700 | 15,028,814 | 14.9 M to 15 M (+0.60 %) |
May 14 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 19.81 | 60,000 | 1,188,600 | 14,938,814 | 14.9 M to 14.9 M (+0.40 %) |
May 14 2009 | ICN | VALEANT PHARMACEUT ... | Morfit G Mason | Director | Grant | A | 0.00 | 6,546 | 0 | 22,010 | 15.5 K to 22 K (+42.33 %) |
May 14 2009 | ICN | VALEANT PHARMACEUT ... | MELAS KYRIAZI THEO | Director | Buy | P | 19.54 | 5,000 | 97,692 | 42,809 | 37.8 K to 42.8 K (+13.22 %) |
May 14 2009 | ICN | VALEANT PHARMACEUT ... | MELAS KYRIAZI THEO | Director | Buy | P | 19.50 | 10,000 | 195,000 | 37,809 | 27.8 K to 37.8 K (+35.96 %) |
May 13 2009 | ICN | VALEANT PHARMACEUT ... | STEFANO STEPHEN F. | Director | Grant | A | 0.00 | 6,546 | 0 | 8,913 | 2.4 K to 8.9 K (+276.55 %) |
May 13 2009 | ICN | VALEANT PHARMACEUT ... | STEFANO STEPHEN F. | Director | Grant | A | 0.00 | 140 | 0 | 2,367 | 2.2 K to 2.4 K (+6.29 %) |
May 13 2009 | ICN | VALEANT PHARMACEUT ... | STEFANO STEPHEN F. | Director | Buy | P | 19.78 | 2,000 | 39,563 | 2,227 | 227 to 2.2 K (+881.06 %) |
May 13 2009 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Grant | A | 0.00 | 6,546 | 0 | 36,231 | 29.7 K to 36.2 K (+22.05 %) |
May 13 2009 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Grant | A | 0.00 | 299 | 0 | 29,685 | 29.4 K to 29.7 K (+1.02 %) |
May 13 2009 | ICN | VALEANT PHARMACEUT ... | MELAS KYRIAZI THEO | Director | Grant | A | 0.00 | 6,546 | 0 | 27,809 | 21.3 K to 27.8 K (+30.79 %) |
May 13 2009 | ICN | VALEANT PHARMACEUT ... | MELAS KYRIAZI THEO | Director | Grant | A | 0.00 | 132 | 0 | 21,263 | 21.1 K to 21.3 K (+0.62 %) |
May 13 2009 | ICN | VALEANT PHARMACEUT ... | LONNER ANDERS | Director | Grant | A | 0.00 | 6,546 | 0 | 7,650 | 1.1 K to 7.7 K (+592.93 %) |
May 13 2009 | ICN | VALEANT PHARMACEUT ... | LONNER ANDERS | Director | Grant | A | 0.00 | 194 | 0 | 1,104 | 910 to 1.1 K (+21.32 %) |
May 13 2009 | ICN | VALEANT PHARMACEUT ... | KUGELMAN LARRY | Director | Grant | A | 0.00 | 6,546 | 0 | 32,841 | 26.3 K to 32.8 K (+24.89 %) |
May 13 2009 | ICN | VALEANT PHARMACEUT ... | KUGELMAN LARRY | Director | Grant | A | 0.00 | 149 | 0 | 26,295 | 26.1 K to 26.3 K (+0.57 %) |
May 13 2009 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 8,560 | 0 | 36,738 | 28.2 K to 36.7 K (+30.38 %) |
May 13 2009 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 228 | 0 | 28,178 | 28 K to 28.2 K (+0.82 %) |
May 13 2009 | ICN | VALEANT PHARMACEUT ... | KOPPES RICHARD | Director | Grant | A | 0.00 | 6,546 | 0 | 26,694 | 20.1 K to 26.7 K (+32.49 %) |
May 13 2009 | ICN | VALEANT PHARMACEUT ... | KOPPES RICHARD | Director | Grant | A | 0.00 | 114 | 0 | 20,148 | 20 K to 20.1 K (+0.57 %) |
May 12 2009 | ICN | VALEANT PHARMACEUT ... | CHAUDHURI BHASKAR | President | Buy | P | 19.50 | 1,538 | 29,991 | 84,572 | 83 K to 84.6 K (+1.85 %) |
May 11 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 19.46 | 100,000 | 1,946,000 | 14,878,814 | 14.8 M to 14.9 M (+0.68 %) |
May 11 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 19.10 | 100,000 | 1,910,000 | 14,778,814 | 14.7 M to 14.8 M (+0.68 %) |
May 11 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 19.38 | 130,000 | 2,519,400 | 14,678,814 | 14.5 M to 14.7 M (+0.89 %) |
May 11 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 19.24 | 100,000 | 1,924,000 | 14,548,814 | 14.4 M to 14.5 M (+0.69 %) |
May 11 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 19.48 | 110,268 | 2,148,021 | 14,448,814 | 14.3 M to 14.4 M (+0.77 %) |
May 11 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 19.64 | 200,000 | 3,928,000 | 14,338,546 | 14.1 M to 14.3 M (+1.41 %) |
May 11 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 19.58 | 200,000 | 3,916,000 | 14,138,546 | 13.9 M to 14.1 M (+1.43 %) |
May 11 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 19.49 | 50,000 | 974,500 | 13,938,546 | 13.9 M to 13.9 M (+0.36 %) |
May 11 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 18.93 | 147,246 | 2,787,367 | 13,888,546 | 13.7 M to 13.9 M (+1.07 %) |
May 11 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 18.94 | 250,000 | 4,735,000 | 13,741,300 | 13.5 M to 13.7 M (+1.85 %) |
May 11 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 18.95 | 200,000 | 3,790,000 | 13,491,300 | 13.3 M to 13.5 M (+1.50 %) |
May 11 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 18.88 | 50,000 | 944,000 | 13,291,300 | 13.2 M to 13.3 M (+0.38 %) |
May 04 2009 | ICN | VALEANT PHARMACEUT ... | CHAUDHURI BHASKAR | President | Buy | P | 17.05 | 1,760 | 30,008 | 83,034 | 81.3 K to 83 K (+2.17 %) |
May 08 2009 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Buy | P | 18.51 | 7,000 | 129,570 | 1,259,716 | 1.3 M to 1.3 M (+0.56 %) |
Apr 27 2009 | ICN | VALEANT PHARMACEUT ... | CHAUDHURI BHASKAR | President | Buy | P | 17.32 | 1,732 | 29,998 | 81,274 | 79.5 K to 81.3 K (+2.18 %) |
Apr 21 2009 | ICN | VALEANT PHARMACEUT ... | CHAUDHURI BHASKAR | President | Buy | P | 17.62 | 1,703 | 30,007 | 79,542 | 77.8 K to 79.5 K (+2.19 %) |
Apr 09 2009 | ICN | VALEANT PHARMACEUT ... | DE SILVA RAJIV | Chief Operating Off ... | Grant | A | 0.00 | 11,595 | 0 | 89,624 | 78 K to 89.6 K (+14.86 %) |
Apr 13 2009 | ICN | VALEANT PHARMACEUT ... | Karlson Elisa A. | EVP & Chief Adminis ... | Grant | A | 0.00 | 5,322 | 0 | 85,771 | 80.4 K to 85.8 K (+6.62 %) |
Apr 09 2009 | ICN | VALEANT PHARMACEUT ... | Blott Peter J | EVP & CFO | Grant | A | 0.00 | 4,750 | 0 | 91,300 | 86.6 K to 91.3 K (+5.49 %) |
Apr 02 2009 | ICN | VALEANT PHARMACEUT ... | STEFANO STEPHEN F. | Director | Grant | A | 0.00 | 210 | 0 | 227 | 17 to 227 (+1,235.29 %) |
Apr 02 2009 | ICN | VALEANT PHARMACEUT ... | MELAS KYRIAZI THEO | Director | Grant | A | 0.00 | 262 | 0 | 21,131 | 20.9 K to 21.1 K (+1.26 %) |
Apr 02 2009 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Grant | A | 0.00 | 559 | 0 | 29,386 | 28.8 K to 29.4 K (+1.94 %) |
Apr 02 2009 | ICN | VALEANT PHARMACEUT ... | LONNER ANDERS | Director | Grant | A | 0.00 | 419 | 0 | 910 | 491 to 910 (+85.34 %) |
Apr 02 2009 | ICN | VALEANT PHARMACEUT ... | KUGELMAN LARRY | Director | Grant | A | 0.00 | 210 | 0 | 26,146 | 25.9 K to 26.1 K (+0.81 %) |
Apr 02 2009 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 419 | 0 | 27,950 | 27.5 K to 28 K (+1.52 %) |
Apr 02 2009 | ICN | VALEANT PHARMACEUT ... | KOPPES RICHARD | Director | Grant | A | 0.00 | 210 | 0 | 20,034 | 19.8 K to 20 K (+1.06 %) |
Apr 01 2009 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Grant | A | 0.00 | 301 | 0 | 28,827 | 28.5 K to 28.8 K (+1.06 %) |
Apr 01 2009 | ICN | VALEANT PHARMACEUT ... | MELAS KYRIAZI THEO | Director | Grant | A | 0.00 | 43 | 0 | 20,869 | 20.8 K to 20.9 K (+0.21 %) |
Apr 01 2009 | ICN | VALEANT PHARMACEUT ... | KUGELMAN LARRY | Director | Grant | A | 0.00 | 151 | 0 | 25,936 | 25.8 K to 25.9 K (+0.59 %) |
Apr 01 2009 | ICN | VALEANT PHARMACEUT ... | LONNER ANDERS | Director | Grant | A | 0.00 | 172 | 0 | 491 | 319 to 491 (+53.92 %) |
Apr 01 2009 | ICN | VALEANT PHARMACEUT ... | KOPPES RICHARD | Director | Grant | A | 0.00 | 151 | 0 | 19,824 | 19.7 K to 19.8 K (+0.77 %) |
Apr 01 2009 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 258 | 0 | 27,531 | 27.3 K to 27.5 K (+0.95 %) |
Apr 01 2009 | ICN | VALEANT PHARMACEUT ... | STEFANO STEPHEN F. | Director | Grant | A | 0.00 | 17 | 0 | 17 | 0 to 17 |
Mar 20 2009 | ICN | VALEANT PHARMACEUT ... | CHAUDHURI BHASKAR | President | Option Exercise | A | 16.63 | 164,212 | 2,730,846 | 164,212 | |
Mar 20 2009 | ICN | VALEANT PHARMACEUT ... | CHAUDHURI BHASKAR | President | Option Exercise | A | 16.63 | 20,756 | 345,172 | 20,756 | |
Mar 20 2009 | ICN | VALEANT PHARMACEUT ... | CHAUDHURI BHASKAR | President | Grant | A | 0.00 | 77,839 | 0 | 77,839 | 0 to 77.8 K |
Mar 12 2009 | ICN | VALEANT PHARMACEUT ... | Karlson Elisa A. | EVP & Chief Adminis ... | Buy | P | 16.97 | 5,322 | 90,314 | 80,449 | 75.1 K to 80.4 K (+7.08 %) |
Mar 12 2009 | ICN | VALEANT PHARMACEUT ... | Blott Peter J | EVP & CFO | Buy | P | 16.78 | 4,750 | 79,728 | 86,550 | 81.8 K to 86.6 K (+5.81 %) |
Mar 09 2009 | ICN | VALEANT PHARMACEUT ... | KOPPES RICHARD | Director | Buy | P | 16.02 | 1,500 | 24,030 | 19,673 | 18.2 K to 19.7 K (+8.25 %) |
Mar 03 2009 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Grant | A | 0.00 | 316 | 0 | 28,526 | 28.2 K to 28.5 K (+1.12 %) |
Mar 03 2009 | ICN | VALEANT PHARMACEUT ... | MELAS KYRIAZI THEO | Director | Grant | A | 0.00 | 158 | 0 | 20,826 | 20.7 K to 20.8 K (+0.76 %) |
Mar 03 2009 | ICN | VALEANT PHARMACEUT ... | KUGELMAN LARRY | Director | Grant | A | 0.00 | 158 | 0 | 25,785 | 25.6 K to 25.8 K (+0.62 %) |
Mar 03 2009 | ICN | VALEANT PHARMACEUT ... | KOPPES RICHARD | Director | Grant | A | 0.00 | 46 | 0 | 18,173 | 18.1 K to 18.2 K (+0.25 %) |
Mar 03 2009 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 92 | 0 | 27,273 | 27.2 K to 27.3 K (+0.34 %) |
Mar 03 2009 | ICN | VALEANT PHARMACEUT ... | DE SILVA RAJIV | Chief Operating Off ... | Buy | P | 17.28 | 11,595 | 200,305 | 78,029 | 66.4 K to 78 K (+17.45 %) |
Mar 02 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | J | 17.53 | 1,075,700 | 18,857,021 | 13,241,300 | 12.2 M to 13.2 M (+8.84 %) |
Mar 02 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Sell | J | 17.53 | 1,075,700 | 18,857,021 | 0 | 1.1 M to 0 (-100.00 %) |
Mar 02 2009 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Buy | P | 17.75 | 2,500 | 44,364 | 28,210 | 25.7 K to 28.2 K (+9.72 %) |
Feb 13 2009 | ICN | VALEANT PHARMACEUT ... | Min Steve T. | EVP and General Cou ... | Grant | A | 0.00 | 39,039 | 0 | 39,039 | 0 to 39 K |
Feb 13 2009 | ICN | VALEANT PHARMACEUT ... | Karlson Elisa A. | EVP & Chief Adminis ... | Grant | A | 0.00 | 49,847 | 0 | 49,847 | 0 to 49.8 K |
Feb 13 2009 | ICN | VALEANT PHARMACEUT ... | DE SILVA RAJIV | Chief Operating Off ... | Option Exercise | A | 22.68 | 99,481 | 2,256,229 | 99,481 | |
Feb 13 2009 | ICN | VALEANT PHARMACEUT ... | DE SILVA RAJIV | Chief Operating Off ... | Option Exercise | A | 22.68 | 18,648 | 422,937 | 18,648 | |
Feb 13 2009 | ICN | VALEANT PHARMACEUT ... | DE SILVA RAJIV | Chief Operating Off ... | Grant | A | 0.00 | 50,117 | 0 | 66,434 | 16.3 K to 66.4 K (+307.15 %) |
Feb 13 2009 | ICN | VALEANT PHARMACEUT ... | DE SILVA RAJIV | Chief Operating Off ... | Grant | A | 0.00 | 16,317 | 0 | 16,317 | 0 to 16.3 K |
Jan 13 2009 | ICN | VALEANT PHARMACEUT ... | LONNER ANDERS | Director | Grant | A | 0.00 | 319 | 0 | 319 | 0 to 319 |
Feb 13 2009 | ICN | VALEANT PHARMACEUT ... | Blott Peter J | EVP & CFO | Grant | A | 0.00 | 47,600 | 0 | 73,600 | 26 K to 73.6 K (+183.08 %) |
Jan 06 2009 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Grant | A | 0.00 | 435 | 0 | 25,710 | 25.3 K to 25.7 K (+1.72 %) |
Jan 06 2009 | ICN | VALEANT PHARMACEUT ... | KUGELMAN LARRY | Director | Grant | A | 0.00 | 163 | 0 | 25,627 | 25.5 K to 25.6 K (+0.64 %) |
Jan 06 2009 | ICN | VALEANT PHARMACEUT ... | MELAS KYRIAZI THEO | Director | Grant | A | 0.00 | 204 | 0 | 20,668 | 20.5 K to 20.7 K (+1.00 %) |
Jan 06 2009 | ICN | VALEANT PHARMACEUT ... | KOPPES RICHARD | Director | Grant | A | 0.00 | 163 | 0 | 18,127 | 18 K to 18.1 K (+0.91 %) |
Jan 06 2009 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 326 | 0 | 12,842 | 12.5 K to 12.8 K (+2.60 %) |
Dec 31 2008 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Grant | A | 0.00 | 254 | 0 | 25,275 | 25 K to 25.3 K (+1.02 %) |
Dec 31 2008 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 169 | 0 | 26,855 | 26.7 K to 26.9 K (+0.63 %) |
Dec 18 2008 | ICN | VALEANT PHARMACEUT ... | Blott Peter J | EVP & CFO | Grant | A | 0.00 | 4,100 | 0 | 34,200 | 30.1 K to 34.2 K (+13.62 %) |
Dec 02 2008 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Grant | A | 0.00 | 328 | 0 | 24,858 | 24.5 K to 24.9 K (+1.34 %) |
Dec 02 2008 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 348 | 0 | 26,609 | 26.3 K to 26.6 K (+1.33 %) |
Nov 25 2008 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Grant | A | 0.00 | 2,859 | 0 | 24,530 | 21.7 K to 24.5 K (+13.19 %) |
Nov 14 2008 | ICN | VALEANT PHARMACEUT ... | Blott Peter J | EVP & CFO | Buy | P | 18.24 | 4,100 | 74,800 | 30,100 | 26 K to 30.1 K (+15.77 %) |
Oct 31 2008 | ICN | VALEANT PHARMACEUT ... | HealthCor Management, L.P. | 10% Owner | Option Exercise | P | 17.50 | 3,000 | 52,500 | 3,000 | |
Oct 31 2008 | ICN | VALEANT PHARMACEUT ... | HealthCor Management, L.P. | 10% Owner | Buy | P | 15.76 | 1,000,000 | 15,760,000 | 10,000,000 | 9 M to 10 M (+11.11 %) |
Oct 29 2008 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Grant | A | 0.00 | 145 | 0 | 21,671 | 21.5 K to 21.7 K (+0.67 %) |
Oct 29 2008 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 92 | 0 | 26,261 | 26.2 K to 26.3 K (+0.35 %) |
Oct 17 2008 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | J | 17.53 | 308,000 | 5,399,240 | 12,165,600 | 11.9 M to 12.2 M (+2.60 %) |
Oct 17 2008 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Sell | J | 17.53 | 308,000 | 5,399,240 | 1,075,700 | 1.4 M to 1.1 M (-22.26 %) |
Oct 03 2008 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Grant | A | 0.00 | 488 | 0 | 21,526 | 21 K to 21.5 K (+2.32 %) |